In terms of treatment, the CART algorithm analysis revealed that BclI and NALP1 gene polymorphisms are closely related to steroid response, emphasizing the role of genetic and demographic factors in predicting steroid efficacy in young patients with IBD (30). Here, NLRP1 is linked to irritable bowel syndrome.